Amanote Research
Register
Sign In
Discovery of Peptidomimetric Antagonists of Estrogen Receptor - Coactivator Interactions: A Novel Strategy to Combat Tamoxifen Drug Resistance
doi 10.21236/ada398889
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2001
Authors
Unknown
Publisher
Defense Technical Information Center
Related search
Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Estrogen-Related Receptor Alpha (ERRa)-Coactivator Interactions as Targets for Discovery of New Anti-Breast Cancer Therapeutics
Discovery of Novel Triazole-Based Opioid Receptor Antagonists
An Estrogen Receptor-Selective Coactivator: A Potential Regulator of Tamoxifen Effectiveness in Breast Cancer Treatment and Prevention
Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
Cancer Research
Cancer Research
Oncology
Functional Interactions Between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Discovery at the Interface: Toward Novel Anti-Proliferative Agents Targeting Human Estrogen Receptor/S100 Interactions
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance
